Compare Stocks › ABBV vs ROP

AbbVie Inc. (ABBV) vs Roper Technologies, Inc. (ROP): Which Is the Better Buy in 2026?

As of 2026-11-01, ABBV is overvalued at $295, with a DCF intrinsic value of $172 and a margin of safety of -71%. ROP is fairly valued at $467, with an intrinsic value of $476 and a margin of safety of 2%. Of the two, ROP has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
ROP
Roper Technologies, Inc.
$466.60

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
ROP
  • ★Gross margin of 69.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★Free cash flow has grown at a 54.2% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • ★Trailing P/E of 18.5x is 38% below the historical average of 29.8x — potentially undervalued relative to its own history.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
ROP
  • ⚠FCF yield of 5.3% suggests reasonable valuation assuming continued moderate growth.
  • ⚠Insiders have sold $6.8M worth of stock in the past 3 months — significant insider liquidation.

Key Valuation Metrics

Learn more →
ABBV
ROP
Valuation
N/A
Free Cash Flow
$2.44B
N/A
FCF Yield
5.28%
50.67
Trailing P/E
18.46
18.24
Forward P/E
18.99
Quality & Moat
29.08%
ROIC
6.62%
N/A
ROE
13.23%
73.72%
Gross Margin
69.67%
0.60
PEG Ratio
1.78
Balance Sheet Safety
N/A
Net Debt / Equity
0.49
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
2.86
2.35%
Dividend Yield
0.78%
ABBV: 5Ties: 2ROP: 1
ABBVROP

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

ROP

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
ROP
$0.46
created per $1 retained over 3 years
Value Destroyer
Σ Retained
$3.50B
Δ Market Cap
+$1.61B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
71.5% Overvalued
Price is 71.5% above estimated fair value
Current Price: $294.89
Fair Value: $172.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
ROP
2.0% Margin of Safety
Price is 2.0% below estimated fair value
Current Price: $466.60
Fair Value: $476.12
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

ROP

What growth rate is the market pricing in at $467?

+10.1%
Market-Implied Owner Earnings Growth
Standard FCF implies +9.5%

The market implies +10.1% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +9.5%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
ROP
69/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
ROP
-2.54
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
ROP
Insiders 0.4%Institutions 106.7%
No. of Institutional Holders1,543
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
ROP
0
Buys (3M)
3
Buys (12M)
Total value (12M): $5.57M
JOYCE THOMAS PATRICK JR
Director
$501,844
@ $358.46 · 2026-02-06
BRINKLEY AMY WOODS
Director
$540,856
@ $450.71 · 2025-11-12
HUNN LAURENCE NEIL
Chief Executive Officer
$4.52M
@ $452.23 · 2025-11-12
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
ROP
2
Sells (3M)
6
Sells (12M)
Total value (12M): $25.86M
STIPANCICH JOHN K
Officer
$1.57M
@ $449.04 · 2026-10-26
CONLEY JASON
Chief Financial Officer
$5.23M
@ $435.53 · 2026-10-23
STIPANCICH JOHN K
Officer
$758,100
@ $379.05 · 2026-07-27
WALLMAN RICHARD F.
Director
$2.32M
@ $361.00 · 2026-07-24
CONLEY JASON
Chief Financial Officer
$2.67M
@ $445.56 · 2025-12-01
HUNN LAURENCE NEIL
Chief Executive Officer
$13.31M
@ $443.57 · 2025-11-11
JOHNSON ROBERT D.
Director
$210,158
@ $525.39 · 2025-08-15
STIPANCICH JOHN K
General Counsel
$846,255
@ $564.17 · 2025-07-23
WALLMAN RICHARD F.
Director
$195,800
@ $556.25 · 2025-07-22
WRIGHT CHRISTOPHER B
Director
$200,277
@ $572.22 · 2025-05-05
CONLEY JASON
Chief Financial Officer
$1.76M
@ $588.19 · 2025-02-25
CROSS BRANDON L
Officer
$433,372
@ $577.83 · 2025-02-04
STIPANCICH JOHN K
General Counsel
$578,040
@ $578.04 · 2025-01-31
CONLEY JASON
Chief Financial Officer
$1.73M
@ $578.05 · 2025-01-31
WALLMAN RICHARD F.
Director
$201,913
@ $575.25 · 2025-01-31
JOHNSON ROBERT D.
Director
$528,092
@ $561.80 · 2024-12-03
HUNN LAURENCE NEIL
Chief Executive Officer
$17.17M
@ $572.47 · 2024-11-08
WRIGHT CHRISTOPHER B
Director
$387,366
@ $568.82 · 2024-11-08
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
ROP
FearGreed
😏Greed(73/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
ROP
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (73)
View ABBV Full AnalysisView ROP Full Analysis

Frequently Asked Questions: ABBV vs ROP

Is AbbVie Inc. or Roper Technologies, Inc. more undervalued in 2026?▼

Based on our discounted cash flow model, ROP trades at a 2.0% margin of safety (intrinsic value $476 vs. price $467), compared to ABBV's -71.5% margin of safety (intrinsic $172 vs. $295).

Which stock has a wider economic moat, AbbVie Inc. or Roper Technologies, Inc.?▼

ABBV scores 82/100 (Wide moat), while ROP scores 69/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?▼

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. ROP scores 3.0 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Roper Technologies, Inc.?▼

ABBV earns 29.1% ROIC versus ROP's 6.6%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Roper Technologies, Inc.'s?▼

ROP's dividend earns a safety score of 94/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). ROP has raised its dividend for 3 consecutive years.

ABBV vs ROP: Which Is the Better Buy in 2026? | SafetyMargin.io